成体干细胞的研究现状与展望

近年来，干细胞特有的生物学特性及其潜在的生物医学应用价值使之成为生命科学领域最热点、最前沿的课题之一。随着对干细胞研究的不断深入，人们发现成体干细胞除了具有较强的自我更新、高度增殖和多向分化潜能外还具有分化方向的可塑性。作者根据国内外研究成果，综述了成体干细胞的“可塑性”研究的最新进展，以及成体干细胞可塑性研究的前景及存在的主要问题。     

造血干细胞研究进展

造血干细胞是具有自我更新、高度增殖和多向分化潜能的细胞群体,在人体造血系统中起着至关重要的作用。本文介绍了造血干细胞的生物学特征、表面标志以及造血干细胞在干细胞移植、细胞治疗和基因治疗等方面的临床应用和前景。     

造血干细胞研究进展

造血干细胞是具有自我更新、高度增殖和多向分化潜能的细胞群体,在人体造血系统中起着至关重要的作用.本文介绍了造血干细胞的生物学特征、表面标志以及造血干细胞在干细胞移植、细胞治疗和基因治疗等方面的临床应用和前景.     

Bmi1基因与干细胞增殖和肿瘤发生研究进展

干细胞是一类具有自我更新能力并可向多种细胞、组织类型分化的细胞。Bmi1是PcG(poly-comb group)家族重要的调控基因,该基因与干细胞的增殖和肿瘤的发生密切相关,在维持干细胞的自我更新能力中起关键的作用。增强干细胞自我更新的能力可以改变干细胞的生物特性,继而导致肿瘤的发生。     

神经干细胞研究进展及其在环境兽医学中的应用

1992年,Reynolds等最先从成年鼠的纹状体和海马中分离出能够进行自我更新、不断分裂增殖且具有多种分化潜能细胞群落,由此提出了神经干细胞（neural stem cells,NSCs）的概念,从而打破了多年来人们一直信为中枢神经细胞是在胚胎时期产生的,成年以后神经细胞的数目不再增加,只会因衰老而发生死亡的论断。Mckay于1997年在Science杂志上将神经干细胞的概念总结为：具有分化为神经元、星形胶质细胞及少突胶质细胞的能力,能自我更新并足以提供大量脑组织细胞的细胞。总之,正因为干细胞具有自我更新能力、多能性或全能性、整合性和转分化性、低免疫原性等特性,所以有着非常重要的理论研究意义和临床应用价值。     

Bmil基因与干细胞增殖和肿瘤发生研究进展

干细胞是一类具有自我更新能力并可向多种细胞、组织类型分化的细胞.Bmil是PcG( polycomb group)家族重要的调控基因,该基因与干细胞的增殖和肿瘤的发生密切相关,在维持干细胞的自我更新能力中起关键的作用.增强干细胞自我更新的能力可以改变干细胞的生物特性,继而导致肿瘤的发生.     

骨骼肌干细胞研究进展

骨骼肌干细胞具有一般干细胞的特点,可以自我更新、繁殖产生更多的干细胞,同时也可以分化成各种各样的具有特定功能的细胞,可作为多种组织工程的种子细胞,有非常重要的研究和应用价值.对骨骼肌干细胞在诱导分化方面的进展进行了阐述,以期能为骨骼肌千细胞的进一步研究提供理论基础.     

胚胎干细胞分离培养研究进展

胚胎干细胞(ESCs)是一种高度未分化,能自我复制、自我更新,在体外连续传代并保持未分化状态和具有发育全能性的细胞.文章从研究概况、体外分离培养、生物学特性、鉴定方法、影响ESCs分离培养的因素、存在问题以及应用前景等方面对胚胎干细胞进行了概述.     

胚胎干细胞的定向诱导分化及其应用前景

胚胎干细胞(embryonic stem cell,ES细胞)主要来自于胚胎发育早期囊胚中内细胞群(i nner cel l mas s,I CM),具有无限增殖、自我更新和多向分化的特性。理论上可以诱导分化为机体中200多种细胞,可作为细胞移植、组织替代,甚至器官克隆的细胞供体,为将来治疗人类诸多难治性疾病提供细胞来源。本文简述了胚胎干细胞的诱导分化方法、定向分化的一些细胞种类以及其应用前景。     

哺乳动物成体干细胞的研究进展

干细胞具有自我更新能力,能够产生高度分化的功能细胞。干细胞按照发育阶段分为胚胎干细胞和成体干细胞。根据干细胞的发育潜能分为三类：全能干细胞、多能干细胞和单能干细胞。胚胎干细胞的发育等级较高,是全能干细胞,而成体干细胞的发育等级较低,是多能或单能干细胞。一般认为成年组织或器官内的干细胞具有组织特异性,只能分化成特定的细胞或组织,然而,研究结果表明,组织特异性干细胞同样具有分化成其他细胞或组织的潜能,这为干细胞的应用开创了更广泛的空间。作者主要综述了干细胞的研究进展及几种成体干细胞的诱导分化。     

毛囊干细胞的研究进展

毛囊干细胞具有干细胞的一般特征,经研究将其定位于毛囊隆突部。毛囊干细胞具有自己特定的表面标志物,并经诱导可分化为各类细胞,笔者对毛囊干细胞在临床上的应用进行了阐述。     

肌源干细胞研究进展

近年研究发现,成体骨骼肌中不但存在单能的成肌干细胞卫星细胞,而且还含有多能的肌源干细胞。肌源干细胞起源于胚胎血管祖细胞,在适当的微环境中,可分化为血细胞、成骨细胞、神经细胞等不同胚层的组织细胞。肌源干细胞的表面标志已被初步认识,对其分化的研究,及其分离纯化的技术研究正在进一步深入。文章对肌源干细胞的起源、分离纯化、表面标志、分化潜能及存在问题与展望做一综述。     

The Amniotic Membrane: Development and Potential Applications – A Review

Foetal membranes are essential tissues for embryonic development, playing important roles related to protection, breathing, nutrition and excretion. The amnion is the innermost extraembryonic membrane, which surrounds the foetus, forming an amniotic sac that contains the amniotic fluid (AF). In recent years, the amniotic membrane has emerged as a potential tool for clinical applications and has been primarily used in medicine in order to stimulate the healing of skin and corneal diseases. It has also been used in vaginal reconstructive surgery, repair of abdominal hernia, prevention of surgical adhesions and pericardium closure. More recently, it has been used in regenerative medicine because the amniotic‐derived stem cells as well as AF‐derived cells exhibit cellular plasticity, angiogenic, cytoprotective, immunosuppressive properties, antitumoural potential and the ability to generate induced pluripotent stem cells. These features make them a promising source of stem cells for cell therapy and tissue engineering. In this review, we discussed the development of the amnion, AF and amniotic cavity in different species, as well as the applicability of stem cells from the amnion and AF in cellular therapy.     

小鼠胚胎干细胞向骨骼肌细胞分化的研究进展

近年来,胚胎干细胞的应用越来越广泛,在体外将小鼠胚胎干细胞诱导分化为肌肉细胞,并且利用这些分化得来的肌肉细胞治疗肌肉退行性疾病,一直是胚胎干细胞研究领域的热点,而胚胎干细胞的分化机制更是其中的难点。目前,用于诱导小鼠胚胎干细胞分化为骨骼肌细胞的方法很多,但分化的效率并不是很高,所以研究胚胎干细胞向骨骼肌细胞方向分化的机制显得尤为重要。文章仅就最近几年对小鼠胚胎干细胞向骨骼肌细胞方向分化的一些方法及其机制作一综述。     

精原干细胞体外培养研究进展

精原干细胞（SSCs）是指位于睾丸生精小管基膜上既能自我更新维持自身群体数量恒定,又能定向分化形成精母细胞,最终形成精子的一类原始干细胞。其体外培养以及近年来兴起的移植、基因转染的深入研究,为探讨精子的发生机制、重建不育个体的精子发生、生产转基因动物提供了新的途径。文章综述了精原干细胞体外培养的研究现状,并对其体外的纯化、鉴定,以及未来的应用进行了介绍,旨在为精原干细胞的研究提供借鉴。     

犬造血干细胞移植的作用机制及应用研究进展

造血干细胞(hematopoietic stem cell, HSC)位于造血系统的顶端, 是造血系统中唯一具有多能性和自我更新能力的细胞, 可以分化为各种功能的血细胞, 维持血液系统的建立和动态平衡, 是目前研究最为透彻、临床应用最为成熟的成体干细胞。造血干细胞的这些重要特性, 使得基于造血干细胞在治病机制研究和临床应用中的研究取得了很大进展。以造血干细胞为基础的再生医学治疗是目前治疗恶性血液病和遗传病的首选方法, 如造血干细胞治疗犬白细胞黏附缺陷综合征、犬遗传性贫血、犬淋巴瘤、犬白细胞减少症、犬X连锁严重联合免疫缺陷病等, 但由于白细胞抗原匹配的供体稀缺、可获得的造血干细胞数量有限等原因, 无法满足临床需求, 因此, 如何通过体外培养获得满足临床需要的造血干细胞成为近年来学者们研究的热点问题。作者参照现有研究成果对造血干细胞的来源和体外分离培养、治病机制进行系统的描述, 并对造血干细胞移植治疗遗传性溶血性贫血、白细胞黏附缺陷综合征、淋巴瘤、白细胞减少症、X连锁严重联合免疫缺陷病的临床研究进行综述, 以期为今后将造血干细胞广泛应用于临床治疗提供参考依据。     

Pluripotent stem cells--model of embryonic development,tool for gene targeting,and basis of cell therapy

Embryonic stem (ES) cells are pluripotent cell lines with the capacity of self-renewal and a broad differentiation plasticity. They are derived from pre-implantation embryos and can be propagated as a homogeneous, uncommitted cell population for an almost unlimited period of time without losing their pluripotency and their stable karyotype. Murine ES cells are able to reintegrate fully into embryogenesis when returned into an early embryo, even after extensive genetic manipulation. In the resulting chimeric offspring produced by blastocyst injection or morula aggregation, ES cell descendants are represented among all cell types, including functional gametes. Therefore, mouse ES cells represent an important tool for genetic engineering, in particular via homologous recombination, to introduce gene knock-outs and other precise genomic modifications into the mouse germ line. Because of these properties ES cell technology is of high interest for other model organisms and for livestock species like cattle and pigs. However, in spite of tremendous research activities, no proven ES cells colonizing the germ line have yet been established for vertebrate species other than the mouse (Evans and Kaufman, 1981; Martin, 1981) and chicken (Pain et al., 1996). The in vitro differentiation capacity of ES cells provides unique opportunities for experimental analysis of gene regulation and function during cell commitment and differentiation in early embryogenesis. Recently, pluripotent stem cells were established from human embryos (Thomson et al., 1998) and early fetuses (Shamblott et al., 1998), opening new scenarios both for research in human developmental biology and for medical applications, i.e. cell replacement strategies. At about the same time, research activities focused on characteristics and differentiation potential of somatic stem cells, unravelling an unexpected plasticity of these cell types. Somatic stem cells are found in differentiated tissues and can renew themselves in addition to generating the specialized cell types of the tissue from which they originate. Additional to discoveries of somatic stem cells in tissues that were previously not thought to contain these kinds of cells, they also appear to be capable of developing into cell types of other tissues, but have a reduced differentiation potential as compared to embryo-derived stem cells. Therefore, somatic stem cells are referred to as multipotent rather than pluripotent. This review summarizes characteristics of pluripotent stem cells in the mouse and in selected livestock species, explains their use for genetic engineering and basic research on embryonic development, and evaluates their potential for cell therapy as compared to somatic stem cells.     

精原干细胞介导法制备转基因羊的研究进展

精原干细胞介导法制备转基因动物是用试验导入的方法将外源基因移入动物细胞并整合到其基因组中,伴随着精原干细胞分化成精子,通过受精最终使外源基因得以表达。近年来,随着对精原干细胞研究的不断深入,人们发现其在建立转基因动物方面具有巨大的应用潜力和优势。作者从精原干细胞的生物学特性及携带外源基因的原理等方面阐述了其应用于转基因动物制备的理论机制,同时介绍了精原干细胞介导法在制备转基因动物方面,特别是转基因羊生产中的应用现状。     

Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells

The aim of the study was to compare in vitro the stemness features of horse progenitor cells derived from bone marrow (BM-MSCs), amniotic fluid (AF-MSCs) and umbilical cord matrix (EUC-MSCs). It has been suggested that there may be a stem cell population within both umbilical cord matrix and amniotic fluid. However, little knowledge exists about the characteristics of these progenitor cells within these sources in the equine species. This study wanted to investigate an alternative and non-invasive stem cell source for the equine tissue engineering and to learn more about the properties of these cells for future cell banking. Bone marrow, umbilical cord and amniotic fluid samples were harvested from different horses. Cells were analyzed for proliferation, immunocytochemical, stem cell gene expression and multilineage plasticity. BM- and AF-MSCs took similar time to reach confluence and showed comparable plating efficiency. All cell lines expressed identical stem cell markers and capability to differentiate towards osteogenic lineage. Almost all cell lines differentiated into the adipogenic lineage as demonstrated by cytochemical staining, even if no adipose gene expression was detectable for AF-MSCs. AF- and EUC-MSCs showed a limited chondrogenic differentiation compared with BM-MSCs as demonstrated by histological and biochemical analyses. These findings suggest that AF-MSCs appeared to be a readily obtainable and highly proliferative cell line from an uninvasive source that may represent a good model system for stem cell biology. More studies are needed to investigate their multilineage potential. EUC-MSCs need to be further investigated regarding their particular behavior in vitro represented by spheroid formation.